冠状动脉作为导致心力衰竭的因素:从三个病例中吸取教训
Ayami Naito1, Takumi Toya1,2, Akane Kawai1
1Department of Cardiology, National Defense Medical Collage, Japan.
Internal medicine (Tokyo, Japan)
|March 30, 2025
概括
冠状动脉 (CAS) 即使没有动脉堵塞,也会导致心力衰竭. 挑测试在三名患者中证实了CAS,用通道阻塞剂治疗改善了他们的心力衰竭症状.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 冠状动脉 (CAS) 是心力衰竭的一个未被认可的原因.
- 即使没有阻塞性冠状动脉疾病,CAS也可能导致心力衰竭.
研究的目的:
- 突出冠状动脉 (CAS) 作为心力衰竭的关键病因.
- 强调挑测试和针对CAS引起的心力衰竭的量身定制治疗的重要性.
主要方法:
- 三名患有心力衰竭和非阻塞性冠状动脉的患者的病例系列.
- 冠状动脉 (CAS) 挑测试以确认心上.
- 心脏磁共振成像 (CMR) 评估缺血模式.
主要成果:
- 在这三个患者中,CAS被确定为心力衰竭的关键病因.
- 在CAS挑测试中,证实了心表.
- 心脏磁共振成像显示出两名患者的缺血模式与CAS相关的损伤一致.
- 通道阻塞剂有效地稳定了心力衰竭的迹象和症状.
结论:
- 冠状动脉 (CAS) 是导致心力衰竭进展的重要因素.
- 挑测试对于诊断CAS诱导的心力衰竭至关重要.
- 早期,包括通道阻塞剂在内的量身定制治疗改善了与CAS相关的心力衰竭患者的结果.
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


